FDA Inspection 1058330 — Rare Disease Therapeutics, Inc.
The FDA completed an inspection of Rare Disease Therapeutics, Inc. on Jun 7, 2018 in Poway, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 7, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Poway, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)